1995-2005年加拿大安大略省糖尿病患病率,发病率和死亡率的趋势:基于人口的研究
Lorraine L Lipscombe1, Janet E Hux2
1Institute for Clinical Evaluative Sciences, Toronto, ON, Canada; Department of Medicine, University of Toronto, Toronto, ON, Canada; Women's College Hospital, Toronto, ON, Canada.
Lancet (London, England)
|March 6, 2007
概括
1995年至2005年间,加拿大安大略省的糖尿病患病率显著增加了69%,超过了全球2030年预测. 这种增长是由于发病率增加和死亡率下降,需要进行公共卫生干预.
科学领域:
- 公共卫生 公共卫生
- 流行病学 流行病学
- 糖尿病研究 糖尿病研究
背景情况:
- 全球糖尿病患病率正在上升,世卫组织的预测可能低估了这种增加.
- 该研究重点关注加拿大安大略省的糖尿病趋势,该地区正在经历显著的人口和健康变化.
研究的目的:
- 评估加拿大安大略省糖尿病患病率,发病率和死亡率的时间趋势.
- 将安大略省的糖尿病率与全球预测进行比较,并确定影响这些趋势的关键人口因素.
主要方法:
- 利用基于人口的数据和来自加拿大安大略省的验证糖尿病数据库.
- 在20岁以上的成年人中检查了糖尿病患病率 (1995-2005),发病率 (1997-2003) 和死亡率 (1995-2005).
- 进行了年龄调整和性别调整的分析,以考虑人口统计学变化.
主要成果:
- 年龄调整后的糖尿病患病率从1995年的5.2%上升到2005年的8.8%,增长了69%.
- 糖尿病发病率在六年内 (1997-2003) 增加了31%,年轻人 (20-49岁) 增加了94%.
- 尽管糖尿病相关死亡率下降了25%,但整体患病率显著上升,特别是在年轻人群中.
结论:
- 十多年来,安大略省的糖尿病患病率大幅增加,到2005年将超过2030年全球预测.
- 糖尿病发病率上升和死亡率下降是糖尿病负担增加的关键驱动因素.
- 紧急公共卫生干预糖尿病预防和改善糖尿病老龄化人口的管理策略至关重要.
相关概念视频
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:26Diabetes Mellitus: Introduction
Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
01:15Diabetes: Symptoms, Diagnosis, and Complications
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...